PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Epiconcept, Paris, France.\', \'Nivel, Utrecht, the Netherlands.\', \'National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain.\', \'Instituto de Salud Pública de Navarra (IdiSNA), Pamplona, Spain.\', \'Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain.\', \'Public Health Scotland, Glasgow, Scotland.\', \'INSERM, Sorbonne Université, Institut Pierre Louis d\'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.\', \'National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain.\', \'Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.\', \'Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.\', \'Royal College of General Practitioners Research and Surveillance Centre, London, UK.\', \'National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.\', \'Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal.\', \'The Public Health Agency of Sweden, Stockholm, Sweden.\', \'Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.\', \'CNR des virus des infections respiratoires, Institut Pasteur, Paris, France.\', \'Laboratoire de Virologie, Université de Corse-Inserm, Corte, France.\', \'National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.\', \'Public Health England, London, England.\', \'Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública, Consumo y Cuidados, La Rioja, Spain.\', \'The members of the I-MOVE-COVID-19 primary care study team are listed in the Investigators tab.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2807/1560-7917.ES.2021.26.29.2100670
?:doi
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34296676
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34296676>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34296676>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all